Haemonetics Corp. (HAE)

62.92 +1.63 (+2.66%) USD  |  NYSE  |  Feb 24, 12:31
More

Haemonetics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for HAE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Abbott Laboratories Upgrade
Boston Scientific Corp. Upgrade
DexCom, Inc. Upgrade
Masimo Corp. Upgrade
Stryker Corp. Upgrade